Paratek Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Paratek Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2023.
  • Paratek Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2023 was $1.65M, a 21.7% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $1.65M +$293K +21.7% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $1.64M +$103K +6.71% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $1.78M +$25K +1.42% Dec 31, 2022 10-Q 2023-08-03
Q3 2022 $1.13M -$688K -37.9% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $1.35M -$753K -35.8% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $1.54M -$238K -13.4% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $1.76M -$253K -12.6% Dec 31, 2021 10-K 2023-03-16
Q3 2021 $1.82M -$105K -5.47% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $2.11M -$19K -0.9% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $1.77M -$548K -23.6% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $2.01M -$504K -20% Dec 31, 2020 10-K 2022-03-14
Q3 2020 $1.92M -$780K -28.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $2.12M -$760K -26.4% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $2.32M -$740K -24.2% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $2.51M +$2.51M Dec 31, 2019 10-K 2021-03-29
Q3 2019 $2.7M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $2.88M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $3.06M Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $0 Dec 31, 2018 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.